Market Place
Sourcing Support
Akums gets DCGI nod for triple combination diabetes medication
27 Jul 2023 //
ECONOMIC TIMES
Glenmark launches Triple FDC of Teneligliptin with Pioglitazone and Metformin
22 Dec 2022 //
INDIANPHARMAPOST
Poxel Announces Results from PII NASH Trial for PXL065
21 Sep 2022 //
BUSINESSWIRE
Poxel Announces Positive Results from Phase 2 NASH Trial (DESTINY-1) for PXL065
29 Aug 2022 //
BUSINESSWIRE
Glenmark launches fixed-dose combination medication for diabetic patients
27 Apr 2022 //
ECONOMICTIMES
Poxel Announces PXL065 Granted FDA FTD for X-linked Adrenoleukodystrophy
16 Feb 2022 //
BUSINESSWIRE
Enforcement Report - Week of February 2, 2022
02 Feb 2022 //
FDA
Enforcement Report - Week of February 12, 2020
12 Feb 2020 //
FDA
Recommendation to ban pioglitazone was made to promote other antidiabetic agent
07 Oct 2019 //
PHARMABIZ
Poxel begins new study of NASH candidate PXL065
18 Sep 2019 //
CLINEICALTRIALSARENA
EMA, FDA Begin Reviewing Heartburn Medicines for Carcinogen
13 Sep 2019 //
RAPS
EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
26 Apr 2019 //
RAPS
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA
Novel Diabetes Drugs Sensitize Cancer Cells to Chemotherapy Agents
02 Jan 2018 //
DDDMAG
Enforcement Report - Week of March 15, 2017
15 Mar 2017 //
FDA
FDA Affirms Bladder Cancer Warning for Pioglitazone
12 Dec 2016 //
MED PAGE TODAY
Experts review banned drugs to consider marketing restrictions, india’s MHFW
26 Apr 2016 //
TWO FOUR INSIGHT
Bitter pill served to 1,670 drug brands
19 Mar 2016 //
BUSINESS STANDARD
Diabetes drug, pioglitazone may prevent recurring stroke, heart attack: Study
18 Feb 2016 //
PHARMABIZ
Health Canada approves Jardiance tablets for adults with type 2 diabetes
30 Nov 2015 //
CPHI-ONLINE
Could Common Diabetes Drugs Help Fight Leukemia?
02 Sep 2015 //
WEBB MD
Takeda’s $2.37 Billion Drug Accord Endangered
14 Aug 2015 //
BLOOMBERG BUSINESS
Takeda submits post-marketing Actos study that shows no link to bladder cancer
04 Aug 2015 //
FIERCE PHARMA ASIA
Takeda completes post-marketing commitment and data submission for pioglitazone containing medicines
30 Jul 2015 //
NEWS MEDICAL
Takeda CEO Weber says turnaround tempo quickens, he`s staying put
06 Apr 2015 //
FIERCE PHAMA ASIA
Takeda Offers $2.2 Billion to Settle Actos Drug Cases
02 Apr 2015 //
BLOOMBERG BUSINESS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.